FY2026 EPS Estimates for Transcat Decreased by Analyst

Transcat, Inc. (NASDAQ:TRNS) – Northland Capmk decreased their FY2026 earnings per share estimates for Transcat in a report released on Monday, December 16th. Northland Capmk analyst E. Jackson now expects that the scientific and technical instruments company will post earnings of $1.92 per share for the year, down from their previous estimate of $2.42. The consensus estimate for Transcat’s current full-year earnings is $1.76 per share. Northland Capmk also issued estimates for Transcat’s FY2027 earnings at $2.19 EPS, FY2028 earnings at $2.50 EPS and FY2029 earnings at $2.86 EPS.

Transcat (NASDAQ:TRNS) last released its earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.12). The business had revenue of $67.83 million for the quarter, compared to analysts’ expectations of $70.30 million. Transcat had a return on equity of 7.36% and a net margin of 6.63%. Transcat’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.41 EPS.

Several other research firms have also recently commented on TRNS. StockNews.com cut Transcat from a “hold” rating to a “sell” rating in a report on Tuesday, October 29th. Northland Securities cut their target price on Transcat from $130.00 to $110.00 and set a “market perform” rating for the company in a research note on Wednesday, October 30th. HC Wainwright reissued a “buy” rating and set a $156.00 price target on shares of Transcat in a research report on Tuesday, October 29th. Oppenheimer reissued an “outperform” rating and issued a $130.00 price objective (down previously from $155.00) on shares of Transcat in a report on Wednesday, October 30th. Finally, Craig Hallum lifted their target price on shares of Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $130.25.

Transcat Trading Up 2.7 %

Shares of NASDAQ TRNS opened at $106.78 on Thursday. The company has a 50-day moving average of $110.27 and a 200 day moving average of $118.87. Transcat has a 12-month low of $94.29 and a 12-month high of $147.12. The stock has a market cap of $982.27 million, a PE ratio of 53.93 and a beta of 0.70.

Institutional Trading of Transcat

Hedge funds and other institutional investors have recently modified their holdings of the business. Conestoga Capital Advisors LLC increased its holdings in Transcat by 17.9% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock valued at $109,561,000 after purchasing an additional 137,830 shares during the last quarter. Royce & Associates LP boosted its position in shares of Transcat by 8.2% during the third quarter. Royce & Associates LP now owns 511,701 shares of the scientific and technical instruments company’s stock worth $61,798,000 after buying an additional 38,774 shares during the period. Champlain Investment Partners LLC grew its stake in shares of Transcat by 22.1% in the third quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company’s stock valued at $49,455,000 after buying an additional 74,169 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Transcat by 5.4% in the 3rd quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company’s stock valued at $26,269,000 after buying an additional 11,106 shares during the period. Finally, State Street Corp lifted its stake in Transcat by 8.1% during the 3rd quarter. State Street Corp now owns 207,230 shares of the scientific and technical instruments company’s stock worth $25,027,000 after acquiring an additional 15,514 shares in the last quarter. 98.34% of the stock is owned by institutional investors and hedge funds.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.